Rebecca L Riding

3PUBLICATIONS
15CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 29, 2021
AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma.

Keitaro Fukuda, Ken Okamura, Rebecca L Riding

|Oct 11, 2020
Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy.

Rebecca L Riding, Jillian M Richmond, Keitaro Fukuda

|Jun 19, 2019
The Role of Memory CD8+ T Cells in Vitiligo.

Rebecca L Riding, John E Harris

Pageof 1

Frequent Collaborators

2 joint publications

Keitaro Fukuda

1 joint publications

Jillian M Richmond

1 joint publications

Ken Okamura

1 joint publications

Xueli Fan